Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -68.46% |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Radiopharm Theranostics Limited (RAD) is a Clinical stage radiotherapeutics company which is developing and commercialising a platform of radiopharmaceutical products for both therapeutic and diagnostic applications in precision oncology.
No incorporation details available.
Head Office | Sydney NSW 2000 |
Website | www.radiopharmtheranostics.com |
Registry | Automic Group |
Auditor | Grant Thornton Audit Pty Ltd |
Date Listed | 25 Nov 2021 |
Date | Event |
---|---|
27/02/2023 | Report (Interim) |
28/04/2023 | Report (Quarterly) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
RAD directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of RAD directors.
No Substantial Shareholders for RAD in our database.
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
22-02-22 | NanoMab Technology Limited | 5,888,798 | 8.33 | 10.70 |
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
No Financial Year End data available |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.